All News & Stories

Fred Kolling lab

High schoolers pulling back the curtain of cancer research

Students from Rivendell Academy get up close to the engine of cancer discovery

View story

Prouty paricticipants hold up yellow ribbons.

42nd annual Prouty raises record-breaking $7.7 million for Dartmouth Cancer Center

Funds raised by The Prouty fuel cancer research, provide equipment for research labs and allow for vital patient and family support services.

View story

Todd W. Miller, PhD

New treatment possibility for ER+ breast cancer is headed toward clinical trials

A new study finds that combining estrogen and PARP inhibitors shows promise in treating ER+ breast cancer.

View story

Photo of Prouty participants from previous event.

Participants in the 42nd annual Prouty benefiting Dartmouth Cancer Center will go all in to end cancer this weekend, July 14-15

Registration remains open through Saturday, July 15

View story

Prouty participants

When the Food Pantry meets The Prouty

New this year, Prouty funds will support the Dartmouth Cancer Center Food Pantry to help make sure no cancer patient goes hungry.

View story

Lesley A. Jarvis, MD, PhD and David J. Gladstone, ScD

FLASH meets Mobetron® in advancing radiation therapy cancer research

Radiation oncology boosts FLASH research studies to the next level.

View story

Saeed Hassanpour, PhD

Introducing the Center for Precision Health and Artificial Intelligence

AI can help deliver rapid and innovative solutions to real-world clinical challenges.

View story

Konstantin Dragnev, MD and Joanne Conroy, MD

Clinical trials: How progress in medicine is made

In this video highlight, Konstantin Dragnev, MD, connects with Joanne Conroy, MD, to answer: what are clinical trials?

View story

Clinical researchers

Video: Clinical trials perspectives

Patients, physicians, and scientists share their thoughts about clinical trials at Dartmouth Cancer Center.

View story

Todd Miller & Gary Schwartz

A promising new strategy to treat metastatic breast cancer

Results of a recent clinical trial show that alternating estrogen and anti-estrogen therapies is effective in treating metastatic breast cancer

View story